MedPath

Effect of Different dialysates on serum potassium

Not Applicable
Conditions
hyperkalemia in hemodialysis patients.
Chronic kidney disease, stage 5
N18.5
Registration Number
IRCT20220703055361N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
160
Inclusion Criteria

hemodialysis for more than 3 months
stable physical and labaratory condition
regular treatment program (3 times dialysis per week)
stable vascular access
stable blood pressure
stable hemodynamic and cardiovascular condition
serum potassium less than or equal to 4.5
The patient should be hospitalized. (for the convenience of measuring potassium 6 hours after the end of dialysis)

Exclusion Criteria

need a blood transfusion for any reason

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum potassium level. Timepoint: Measurement of serum potassium in patients before dialysis, immediately after dialysis, 6 hours after dialysis. Method of measurement: Serum potassium measurement of patients in the laboratory by electrode method and using EasyLyte REF 2124 device.;Dialysate potassium level. Timepoint: Measurement of potassium level of dialysate during dialysis from afferent and efferent coupling. Method of measurement: dialysate potassium measurement in the laboratory by electrode method and using EasyLyte REF 2124 device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath